Observational Study of the Treatment and Follow-up of Patients With Type II Diabetes Receiving Bitherapy With or Without Januvia/Xelevia.
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Sitagliptin (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Odyssee
- Sponsors Merck Sharp & Dohme
- 17 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 22 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 14 Mar 2012 Planned end date changed from 1 Mar 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History